Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids

European Respiratory Journal

Volumn 9, Issue 9, 1996, Pages 1885-1890

  Faurschou, P ^a   Steffensen, I ^a   Jacques, L ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; beta2 agonists; Efficacy; Safety; Salmeterol; Steroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL; SALMETEROL; STEROID;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

EID: 0029791974     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09091885     Document Type: Article

References (10)

1. 2-adrenoceptor agonist: a comparison with salbutamol. Thorax 1988; 43:674-678.
2. Dahl R, Earnshaw JS, Palmer JBD. Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991; 4: 1178-1184.
3. Kemp JP, Bierman CW, Cocchetto DM. Dose-response study of inhaled salmeterol in asthmatic patients with 24 hour spirometry and Holter monitoring. Ann Allergy 1993; 70:316-322.
4. Palmer JBD, Stuart AM, Shepherd GL, Viskum K. Inhaled salmeterol in the treatment of patients with moderate-to-severe reversible obstructive airways disease: a 3 month comparison of the efficacy and safety of twice daily salmeterol (100 μg) with salmeterol (50 μg). Respir Med 1992; 86:409-417.
5. Faurshou P. Chronic dose-ranging studies with salmeterol. Eur Respir Rev 1991; 1:282-287.
6. Britton MG, Earnshaw JS, Palmer JBD. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992; 5: 1062-1067.
7. Lundback B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 1993; 48:148-153.
8. Boyd G. Salmeterol xinafoate: a placebo-controlled study in severe asthmatics currently being considered for maintenance Oral corticosteroid therapy (Abstract). Am Rev Respir Dis 1993; 147 (4): A61.
9. International consensus report on the diagnosis and management of asthma. Clin Exp Allergy 1992; 22 (Suppl.):1-72.
10. Woolcock A, Lundback B, Ringdal OLN, Jacques LA. Comparison of the effect of addition of salmeterol with, doubling the inhaled steroid dose in asthmatic patients (Abstract). Am J Respir Crit Care Med 1994; 149 (4): A280.